Chronic Pain Clinical Trial
Official title:
Mobile Coach for Parents of Children and Adolescents With Chronic Pain
Verified date | April 2018 |
Source | University of California, Los Angeles |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic pain is estimated to affect 20% to 35% of children and adolescents around the world,
and is associated with increased risk of anxiety and depression among children and
adolescents, as well as coping challenges, anxiety, depression, and anger in their parents.
For parents, learning to manage stress is critical, as parents play a significant role in a
child's experience of pain. Parental behaviors such as over-involvement, solicitousness and
rejection are associated with decreased functioning, including higher school absenteeism in
children and teens. A number of interventions demonstrate that teaching skills to parents can
have a direct and positive impact on the health of children and adolescents with chronic
pain. The investigators propose to create and test the BodiMojo Parent Buddy which will
provide parents with real-time, tailored and adaptive coping and stress management support
and will provide a curriculum of skills for responding to a child in pain in order to promote
child functioning.
Thirty parents of children ages 8-18 who have been diagnosed with a non-cancer chronic pain
condition will participate in this user-testing study. Parents will complete a brief set of
questionnaires before and after the intervention, and will be instructed to open and use the
app each day for 30 days. Participants will complete audio mindfulness exercises, watch brief
video clips, and read psychoeducational information about pain, coping, and communication
skills. Post-intervention questionnaires will also include an acceptance test to assess
participants' opinions about the helpfulness and usability of the app. Parent participation
is expected to take around 3.5 hours total over the 30 day study period.
Status | Completed |
Enrollment | 34 |
Est. completion date | March 13, 2018 |
Est. primary completion date | March 13, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Parents who self-report parenting a child or adolescent ages 8-18 with non-cancer chronic pain. - Daily use of a smartphone (iOS, Android, or Windows) or tablet. - Ability to speak and understand English. Exclusion Criteria: - Inability to provide consent - Inability to speak and understand English |
Country | Name | City | State |
---|---|---|---|
United States | UCLA Pediatric Pain and Palliative Care Program Research Offices | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles | BodiMojo, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ratio of the days during the 30-day intervention period during which participants use the app | Determined by how often participants engaged and used certain features. To be considered feasible, participants must have opened the app on at least half of the days. | At the conclusion of the final day of the intervention (Day 30) | |
Primary | Acceptance | Determined by participants' responses to acceptance test questions in the following domains: (1) how much the participant liked the various app features; (2) how much participants liked the video and supplementary content; and (3) helpfulness of various app features. Responses will be given on a one to seven-point-scale ranging "terrible" to "excellent." The intervention will be deemed acceptable if at least 80% of participants rate each question an average of at least "5" ("good") on the 7-point scale. | Within 7 days of competing the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|